Company news
Shanghai Yizhong Pharmaceutical Co. Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on "Corporate Value and Return Enhancement" Action Plan 2025
June 6, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
May 29, 2025
Announcement on Plan of Shareholding Reduction by Shareholders through Call Auction
May 20, 2025
Notice on Convening the 2024 Annual General Meeting
May 8, 2025
Announcement on Attending the 2024 Annual Collective Performance Briefing for Innovative Drug Companies on SSE STAR Market and the Q1 2025 Performance Briefing
April 25, 2025
Special Report on Deposit and Use of Raised Funds in 2024
April 22, 2025
Indicative Announcement on Equity Change of Shareholders Reaching an Integral Multiple of 1%
March 25, 2025
Announcement of the Vesting Results and Stock Listing for the Reserved Grant of Shares in the 2022 Restricted Stock Incentive Plan's Initial Vesting Period
March 7, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on the Resignation of Non-independent Director
January 17, 2025
Announcement on Implementation Result of Repurchasing Shares and Share Changes
December 26, 2024
Announcement of the Vesting Results and Stock Listing for the First Grant of Shares in the 2022 Restricted Stock Incentive Plan's Initial Vesting Period
December 16, 2024
Announcement on Convening the Q3 2024 Performance Briefing
December 10, 2024
Announcement on Progress in Repurchasing Shares through Call Auction
December 3, 2024
Announcement on Inclusion of Core Product of Paclitaxel Polymer Micelles for Injection into the Catalogue Of Drugs For Basic National Medical Insurance
November 28, 2024
Announcement on Resolution of the 8th Meeting of the 2nd Board of Directors
November 26, 2024
Announcement on Resolution of the 7th Meeting of the 2nd Board of Supervisors
October 28, 2024
Announcement on Obtaining Notice of Approval for Drug Clinical Trials
October 15, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
October 9, 2024